The University of Southampton
University of Southampton Institutional Repository

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
Background: Previous analyses of risk factors for glucocorticoid (GC)-induced osteoporosis have focused on the estimation of relative rather than absolute fracture probability.
Aim: To estimate risk scores for the individual probability of fracture in GC users.
Design: Retrospective data analysis.Methods: We evaluated all patients aged 40 years or older with a prescription for oral GCs in the General Practice Research Database (GPRD), which comprises the computerized medical records of around 7 million UK subjects. Individual risk factors for osteoporotic fractures were identified, and combined in a predictive model for 10-year absolute fracture risk.
Results: Of 191?752 oral GC users aged =40 years, 7412 experienced an osteoporotic fracture. Several characteristics independently contributed to the fracture risk score (GC therapy, age, gender, fall history, fracture history, body mass index, smoking, previous diagnoses, use of medication, recent hospitalization and indication for GC treatment). Scores of 30, 40 and 50 corresponded to absolute 5-year fracture risks of 6.2%, 15.3% and 35.2%, respectively. A woman aged 65 years with RA, low BMI, and a previous history of fracture and falls, who used 15?mg GC daily (total risk score 54) would have a 5-year fracture risk of 47% (a man with similar history, 30.1%). Short-term use of high-dose GC therapy (=30?mg) was associated with only a small increased risk of osteoporotic fracture (RR 1.21, 95%CI 1.04–1.42) in patients with a history of GC use.
Discussion: This risk score helps to predict an individual's risk of fracture during GC use. Decisions about bone protection treatment could be based on long-term risks of fracture.
1460-2725
191-198
Van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Geusens, P.
4ff22618-fc20-494f-aa5d-2747d6b66f65
Pols, H.A.
e6027242-396b-4a1d-af3c-b9ea9e960dfa
De Laet, C.
22d6d32e-6844-42a2-abd0-6e17b4592971
Leufkens, H.G.
6f387677-0ec5-408b-bdbc-7a50d49631b6
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Geusens, P.
4ff22618-fc20-494f-aa5d-2747d6b66f65
Pols, H.A.
e6027242-396b-4a1d-af3c-b9ea9e960dfa
De Laet, C.
22d6d32e-6844-42a2-abd0-6e17b4592971
Leufkens, H.G.
6f387677-0ec5-408b-bdbc-7a50d49631b6
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6

Van Staa, T.P., Geusens, P., Pols, H.A., De Laet, C., Leufkens, H.G. and Cooper, C. (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM: An International Journal of Medicine, 98 (3), 191-198.

Record type: Article

Abstract

Background: Previous analyses of risk factors for glucocorticoid (GC)-induced osteoporosis have focused on the estimation of relative rather than absolute fracture probability.
Aim: To estimate risk scores for the individual probability of fracture in GC users.
Design: Retrospective data analysis.Methods: We evaluated all patients aged 40 years or older with a prescription for oral GCs in the General Practice Research Database (GPRD), which comprises the computerized medical records of around 7 million UK subjects. Individual risk factors for osteoporotic fractures were identified, and combined in a predictive model for 10-year absolute fracture risk.
Results: Of 191?752 oral GC users aged =40 years, 7412 experienced an osteoporotic fracture. Several characteristics independently contributed to the fracture risk score (GC therapy, age, gender, fall history, fracture history, body mass index, smoking, previous diagnoses, use of medication, recent hospitalization and indication for GC treatment). Scores of 30, 40 and 50 corresponded to absolute 5-year fracture risks of 6.2%, 15.3% and 35.2%, respectively. A woman aged 65 years with RA, low BMI, and a previous history of fracture and falls, who used 15?mg GC daily (total risk score 54) would have a 5-year fracture risk of 47% (a man with similar history, 30.1%). Short-term use of high-dose GC therapy (=30?mg) was associated with only a small increased risk of osteoporotic fracture (RR 1.21, 95%CI 1.04–1.42) in patients with a history of GC use.
Discussion: This risk score helps to predict an individual's risk of fracture during GC use. Decisions about bone protection treatment could be based on long-term risks of fracture.

This record has no associated files available for download.

More information

Published date: 2005

Identifiers

Local EPrints ID: 26073
URI: http://eprints.soton.ac.uk/id/eprint/26073
ISSN: 1460-2725
PURE UUID: 389d8ab3-3f39-4181-b0d5-a7ae386f849d
ORCID for C. Cooper: ORCID iD orcid.org/0000-0003-3510-0709

Catalogue record

Date deposited: 20 Apr 2006
Last modified: 18 Mar 2024 02:44

Export record

Contributors

Author: T.P. Van Staa
Author: P. Geusens
Author: H.A. Pols
Author: C. De Laet
Author: H.G. Leufkens
Author: C. Cooper ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×